In parallel, cisplatin treatment of NSCLC specimens and A549 cell line also showed an increased number of CD133+ cells and exhibited higher autophagy levels, which was reversed by chloroquine (QC). This evidence concerns the gene PROM1 and non-small cell lung carcinoma.